Clinical Trial Update: A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and immunogenicity of the ChimeriVax-JE live attenuated vaccine in healthy adults; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis
• Japanese Encephalitis

Drugs mentioned

• ChimeriVax-JE (live attenuated Japanese encephalitis vaccine)

Snippet

Sponsor: Sanofi | Conditions: Encephalitis, Japanese Encephalitis | Phase 2 | Status: COMPLETED | Results posted: 2011-04-29